CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

128 hedge funds and large institutions have $884M invested in Crinetics Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 28 reducing their positions, and 13 closing their positions.

Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
2.05%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
20
Increased
59
Reduced
28
Closed
13
Calls
$472K
Puts
$2K
Net Calls
+$470K
Net Calls Change
+$447K

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$14.9M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$58.4M
3
O
3
OrbiMed
New York
$63.4M
4
GKIM
4
GW&K Investment Management
Massachusetts
$8.62M
5
Morgan Stanley
5
Morgan Stanley
New York
$10.5M

Top Sellers

1
B
1
Braidwell
Connecticut
$32.4M
2
DTC
2
Deep Track Capital
Connecticut
$0
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$3.64M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$14.8M
5
SFM
5
Sphera Funds Management
Israel
$1.33M
Name Market Value Shares Shares
Change 		Shares
Change %
DCM
1
Driehaus Capital Management
Illinois
$84.9M 5,289,519 -335,225 -6%
BlackRock
2
BlackRock
New York
$63.5M 3,956,358 +38,869 +1%
O
3
OrbiMed
New York
$63.4M 3,950,796 +753,920 +24%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$58.4M 3,635,526 +831,041 +30%
PA
5
Perceptive Advisors
New York
$57.1M 3,554,887 -484,389 -12%
BI
6
BVF Inc
California
$44M 2,736,613 – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$43.3M 2,693,062 +306,675 +13%
BCLSI
8
Bain Capital Life Sciences Investors
Massachusetts
$37M 2,305,558 – –
State Street
9
State Street
Massachusetts
$35.6M 2,218,794 +214,010 +11%
B
10
Braidwell
Connecticut
$32.4M 2,019,714 -1,449,960 -42%
FLAM
11
First Light Asset Management
Minnesota
$26M 1,619,125 +289,812 +22%
FLSM
12
Frazier Life Sciences Management
California
$22.7M 1,414,823 – –
EC
13
EcoR1 Capital
California
$21.4M 1,330,263 – –
PBA
14
Paradigm Biocapital Advisors
New York
$18.2M 1,133,782 +243,677 +27%
NHAS
15
Novo Holdings A/S
Denmark
$17.7M 1,100,000 +362,943 +49%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$15.3M 954,860 +33,630 +4%
T. Rowe Price Investment Management
17
T. Rowe Price Investment Management
Maryland
$14.9M 929,369 +929,369 New
Fidelity Investments
18
Fidelity Investments
Massachusetts
$14.8M 920,958 -962,160 -51%
FC
19
Finepoint Capital
Massachusetts
$13.9M 868,427 +45,682 +6%
5VM
20
5AM Venture Management
California
$13.8M 862,286 – –
OM
21
Opaleye Management
Massachusetts
$12.6M 785,794 +53,794 +7%
SVCM
22
Saturn V Capital Management
Texas
$11.9M 741,043 +117,224 +19%
BNP Paribas Asset Management
23
BNP Paribas Asset Management
France
$11.1M 691,201 +80,511 +13%
Morgan Stanley
24
Morgan Stanley
New York
$10.5M 652,916 +500,328 +328%
GKIM
25
GW&K Investment Management
Massachusetts
$8.62M 536,880 +536,880 New
1
2 3 4 5